Mankind Pharma Ltd (NSE:MANKIND) — Stock Price

Rs2474.90 INR
▼ -1.00% today

Mankind Pharma Ltd (NSE:MANKIND) is currently trading at Rs2474.90 INR, down 1.00% today. Over the past 52 weeks, shares have ranged between Rs1927.40 and Rs2617.90. This page tracks Mankind Pharma Ltd's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Mankind Pharma Ltd worth.

Mankind Pharma Ltd (MANKIND) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Mankind Pharma Ltd's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Mankind Pharma Ltd Income Statement — Revenue, Profit & Earnings by Year

Mankind Pharma Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs142.78 Billion Rs122.07 Billion Rs102.59 Billion Rs87.49 Billion Rs77.82 Billion
Cost of Revenue Rs81.22 Billion Rs35.69 Billion Rs32.57 Billion Rs29.62 Billion Rs24.70 Billion
Gross Profit Rs61.55 Billion Rs86.38 Billion Rs70.02 Billion Rs57.87 Billion Rs53.12 Billion
Research & Development — Rs2.32 Billion Rs254.54 Million Rs254.54 Million Rs20.39 Million
SG&A Rs15.01 Billion Rs27.18 Billion Rs22.98 Billion Rs10.95 Billion Rs1.25 Billion
Total Operating Expenses Rs34.24 Billion Rs61.22 Billion Rs47.63 Billion Rs41.45 Billion Rs34.28 Billion
Operating Income Rs27.31 Billion Rs25.16 Billion Rs22.39 Billion Rs16.42 Billion Rs18.84 Billion
EBITDA Rs38.58 Billion Rs35.58 Billion Rs28.04 Billion Rs20.37 Billion Rs21.97 Billion
EBIT Rs29.72 Billion Rs29.37 Billion Rs24.26 Billion Rs17.12 Billion Rs20.30 Billion
Interest Expense Rs6.39 Billion Rs4.08 Billion Rs278.20 Million Rs419.88 Million Rs202.31 Million
Income Before Tax Rs23.33 Billion Rs25.16 Billion Rs23.98 Billion Rs16.71 Billion Rs19.75 Billion
Income Tax Expense Rs3.95 Billion Rs5.10 Billion Rs4.57 Billion Rs3.62 Billion Rs5.22 Billion
Net Income Rs19.13 Billion Rs19.91 Billion Rs19.13 Billion Rs12.82 Billion Rs14.33 Billion

Mankind Pharma Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Mankind Pharma Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs280.80 Billion Rs277.60 Billion Rs119.63 Billion Rs97.15 Billion Rs91.48 Billion
Total Current Assets Rs69.54 Billion Rs69.88 Billion Rs65.68 Billion Rs43.28 Billion Rs44.07 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs15.37 Billion Rs16.91 Billion Rs7.46 Billion Rs12.24 Billion Rs9.77 Billion
Net Receivables Rs17.34 Billion Rs15.38 Billion Rs8.48 Billion Rs6.06 Billion Rs4.27 Billion
Inventory Rs21.44 Billion Rs20.94 Billion Rs15.53 Billion Rs14.98 Billion Rs17.60 Billion
Property, Plant & Equipment — — — — —
Goodwill Rs64.93 Billion Rs64.93 Billion Rs200.22 Million Rs200.22 Million Rs204.42 Million
Total Liabilities Rs115.18 Billion Rs131.91 Billion Rs23.87 Billion Rs20.67 Billion Rs28.31 Billion
Total Current Liabilities Rs65.07 Billion Rs56.64 Billion Rs21.20 Billion Rs18.63 Billion Rs26.23 Billion
Long-term Debt Rs28.21 Billion Rs55.26 Billion Rs248.70 Million Rs231.47 Million Rs491.94 Million
Net Debt Rs58.29 Billion Rs79.57 Billion Rs-1.75 Billion Rs-1.34 Billion Rs5.71 Billion
Total Stockholder Equity Rs163.00 Billion Rs143.32 Billion Rs93.63 Billion Rs74.35 Billion Rs61.55 Billion
Retained Earnings Rs138.04 Billion Rs119.07 Billion Rs99.19 Billion Rs80.12 Billion Rs67.35 Billion

Mankind Pharma Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Mankind Pharma Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs25.16 Billion Rs24.13 Billion Rs21.52 Billion Rs18.13 Billion Rs9.20 Billion
Capital Expenditures Rs6.26 Billion Rs4.61 Billion Rs3.82 Billion Rs8.32 Billion Rs23.46 Billion
Free Cash Flow Rs18.90 Billion Rs19.53 Billion Rs17.70 Billion Rs9.53 Billion Rs-14.26 Billion
Investing Cash Flow Rs-2.54 Billion Rs-126.92 Billion Rs-20.82 Billion Rs-10.54 Billion Rs-13.69 Billion
Financing Cash Flow Rs-22.89 Billion Rs102.33 Billion Rs52.66 Million Rs-7.40 Billion Rs6.05 Billion
Dividends Paid Rs412.70 Million — — — —
Stock-Based Compensation Rs182.40 Million Rs266.40 Million Rs231.86 Million Rs591.00K —
Depreciation Rs8.86 Billion Rs6.21 Billion Rs3.98 Billion Rs3.26 Billion Rs1.67 Billion
Change in Cash Rs754.10 Million Rs218.72 Million Rs771.87 Million Rs217.60 Million Rs1.56 Billion

Mankind Pharma Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Mankind Pharma Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Oct 29, 2026 — 16.80 —
Jul 30, 2026 13.74 13.60 +1.03%
May 19, 2026 13.89 9.90 +40.30%
Feb 03, 2026 11.99 11.93 +0.50%
Nov 06, 2025 12.38 12.43 -0.40%
Jun 30, 2025 10.60 11.12 -4.65%
May 21, 2025 10.29 8.60 +19.65%
Jan 23, 2025 9.44 11.64 -18.90%